Scientists at Massachusetts General Hospital have developed a microfluidic device to capture tumor-derived extracellular vesicles from patient blood samples. The device paves the way for minimally invasive characterization and monitoring of difficult-to-treat cancers, such as glioblastoma.
Assessing biomarkers present in the blood is a promising w (Read more...)